(9266) Elca
Payments companies reported to CMS as associated with (9266) Elca. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (9266) Elca, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (9266) Elca
These are the largest totals companies reported as associated with (9266) Elca. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $1,422.22 |
| Bradley Nelson | Reno, NV | Interventional Cardiology | $1,010.15 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $744.44 |
| Dexter De Leon | Tucson, AZ | Interventional Cardiology | $457.17 |
| Philipp Wiesner | Springfield, MO | Interventional Cardiology | $407.16 |
| Corwin Thomas | Lafayette, LA | Cardiovascular Disease | $399.18 |
| Santhosh Mathews | Bradenton, FL | Interventional Cardiology | $358.39 |
| Andrew Kwa | San Jose, CA | Interventional Cardiology | $330.89 |
| Tai Pham | Sacramento, CA | Internal Medicine | $314.53 |
| Amod Amritphale | Springfield, MO | Interventional Cardiology | $293.93 |
Prescribed (9266) Elca?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.